| Cohance Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543064 |
NSE Symbol : COHANCE |
P/E(TTM) : 54.68 |
|
ISIN Demat : INE03QK01018 |
Div & Yield% : 0.00 |
EPS(TTM) : 9.70 |
|
Book Value(₹) : 115.25 |
Market Cap(₹Cr) : 20,289.45 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,093.51 | 1,051.35 | 1,330.08 | 1,320.22 | 1,009.72 |
| Other Income | 53.98 | 56.61 | 44.55 | 187.79 | 14.24 |
| Stock Adjustments | -86.53 | -49.16 | 20.94 | 60.35 | 8.37 |
| Total Income | 1,060.96 | 1,058.80 | 1,395.57 | 1,568.36 | 1,032.33 |
| EXPENDITURE : | |||||
| Raw Materials | 212.51 | 265.88 | 421.36 | 459.46 | 310.32 |
| Power and Fuel Cost | 42.19 | 48.30 | 71.35 | 59.55 | 44.20 |
| Other Manufacturing Expenses | 111.71 | 88.31 | 101.96 | 115.25 | 90.76 |
| Selling and Administration Expenses | 47.84 | 37.51 | 43.57 | 52.38 | 44.93 |
| Miscellaneous Expenses | 31.86 | 21.10 | 13.50 | 11.17 | 8.61 |
| Employee Benefit Expenses | 198.30 | 135.23 | 108.58 | 100.48 | 76.23 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 416.55 | 462.47 | 635.24 | 770.08 | 457.28 |
| Interest | 8.00 | 7.45 | 12.75 | 8.53 | 11.66 |
| Gross Profit | 408.55 | 455.02 | 622.49 | 761.55 | 445.62 |
| Depreciation | 57.20 | 54.60 | 43.10 | 39.10 | 31.64 |
| Profit Before Tax | 351.35 | 400.42 | 579.39 | 722.45 | 413.98 |
| Current Tax | 92.37 | 97.36 | 142.45 | 157.63 | 101.72 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -12.73 | 6.59 | 4.34 | 6.72 | 3.62 |
| Reported Net Profit | 271.71 | 296.47 | 432.60 | 558.10 | 308.65 |
| Extraordinary Items | -0.06 | -0.05 | 10.55 | 14.53 | 2.51 |
| Adjusted Net Profit | 271.77 | 296.52 | 422.05 | 543.57 | 306.14 |
| Adjustment below Net Profit | 0.57 | -0.32 | -0.26 | -0.76 | -0.84 |
| Profit/Loss Balance carried down | 1,767.06 | 1,470.91 | 1,276.39 | 835.88 | 568.52 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 218.65 | 116.83 | 40.46 |
| P & L Balance carried down | 2,039.34 | 1,767.06 | 1,490.07 | 1,276.39 | 835.88 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 600.00 | 500.00 | 200.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 6.00 | 5.00 | 2.00 |
| Earnings Per Share-Unit Curr | 10.67 | 11.64 | 16.99 | 21.92 | 12.12 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 90.95 | 79.67 | 68.72 | 59.74 | 41.84 |
| Book Value(Adj)-Unit Curr | 90.95 | 79.67 | 68.72 | 59.74 | 41.84 |